Search Results

Patients with cardiomyopathy have abnormally short telomeres in the cells responsible for heart contraction, Stanford researchers find. This disease hallmark opens new pathways for drug discovery.

Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.

Teri Longacre, John Sunwoo and Roeland Nusse receive endowed appointments.

A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by a Stanford researcher.

The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.

Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.

Fanconi anemia is a rare but deadly disease thought to be the result of aldehyde-induced DNA damage. Now, Stanford researchers are developing a test that could help kids with the disease and millions more with related conditions.

Stanford researchers used genetic-editing tools and stem cell technology to uncover whether a genetic mutation linked to a heart rhythm disorder was benign or pathogenic.

Mark Krasnow was named the Paul and Mildred Berg Professor, and Beverly Mitchell was named the Laurie Kraus Lacob Director of the Stanford Cancer Institute.

The award, which includes a gift of 100 million yen (about $913,000), recognizes the neuroscientist for pioneering and advancing a technology for studying brain circuits.